Logo
Thursday, 28 March 2024
Friday, 20 Dec 2019 07:00 pm

HempMeds®, Subsidiary of Medical Marijuana, Inc., Becomes One of the First Companies to Join Recently Launched Leafly Market

"This is a phenomenal opportunity for our Company to expand its loyal customer base online and reach new consumers who are looking to make knowledgeable CBD purchasing decisions," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "With the CBD market estimated by the Brightfield Group to reach $22 billion by 2022, we have a tremendous opportunity to capitalize on its current popularity and bring significant shareholder value."

newsImage
 

 Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® has become one of the first 21 companies to be listed on the Leafly Market, an online store with the largest selection of hemp-derived cannabidiol (CBD) products independently tested for cannabinoid potency, pesticides and heavy metals.

"We are excited and hopeful that Leafly has created a market for companies such as ourselves who want to create and sell safe, consistent CBD products that consumers can trust," said HempMeds® President Todd Morrow. "There's still a lot to be learned about the many benefits of CBD but this new platform brings another layer of confidence to the legitimacy of our products and our mission to expand access to CBD worldwide."

All products on Leafly Market have been independently tested by Leafly Certified Labs to ensure accurate CBD levels, THC levels at or below legal requirements, and freedom from dangerous levels of heavy metals and pesticides. The Leafly Market also offers consumers detailed educational content and the ability to chat with product experience experts in real-time, allowing an additional opportunity for new HempMeds® customers to learn more about its products.

"This is a phenomenal opportunity for our Company to expand its loyal customer base online and reach new consumers who are looking to make knowledgeable CBD purchasing decisions," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "With the CBD market estimated by the Brightfield Group to reach $22 billion by 2022, we have a tremendous opportunity to capitalize on its current popularity and bring significant shareholder value."


Neha Pandey

Aware of her elements, Neha writes the best articles across industries including electronics & semiconductors, automotive & transportation and food & beverages. Being from the finance background she has the ability to understand the dynamics of every industry and analyze the news updates to form insightful articles. Neha is an energetic person interested in music, travel, and entertainment. Since past 5 years, she written extensively on sectors like technology, finance and healthcare.


Smarter Decisions with Smart News

Smart Market News is committed to getting its readers the latest updates and insights on industries that help in making “smarter” business decisions. With insights and inputs from corporate decision makers, we bring you the stories of adopting innovative solutions and strategies that have been changing the world. Our editorial insights on products, solutions, companies, and adoption of best practices not only help in understanding the markets better, but also prove to be a complete package for your information needs.

Subscribe to our newsletter
Get the latest in your inbox weekly Sign up for the fully charged newsletter
© The News and Media Division of The Insight Partners 2024 | All Rights Reserved | Privacy Policy